HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma.

Abstract
Cancer development is influenced by hereditary mutations, somatic mutations due to random errors in DNA replication, or external factors. It remains unclear how distinct cell-intrinsic and -extrinsic factors impact oncogenesis within the same tissue type. We investigated murine soft tissue sarcomas generated by oncogenic alterations (KrasG12D activation and p53 deletion), carcinogens (3-methylcholanthrene [MCA] or ionizing radiation), and in a novel model combining both factors (MCA plus p53 deletion). Whole-exome sequencing demonstrated distinct mutational signatures in individual sarcoma cohorts. MCA-induced sarcomas exhibited high mutational burden and predominantly G-to-T transversions, while radiation-induced sarcomas exhibited low mutational burden and a distinct genetic signature characterized by C-to-T transitions. The indel to substitution ratio and amount of gene copy number variations were high for radiation-induced sarcomas. MCA-induced tumors generated on a p53-deficient background showed the highest genomic instability. MCA-induced sarcomas harbored mutations in putative cancer-driver genes that regulate MAPK signaling (Kras and Nf1) and the Hippo pathway (Fat1 and Fat4). In contrast, radiation-induced sarcomas and KrasG12Dp53-/- sarcomas did not harbor recurrent oncogenic mutations, rather they exhibited amplifications of specific oncogenes: Kras and Myc in KrasG12Dp53-/- sarcomas, and Met and Yap1 for radiation-induced sarcomas. These results reveal that different initiating events drive oncogenesis through distinct mechanisms.
AuthorsChang-Lung Lee, Yvonne M Mowery, Andrea R Daniel, Dadong Zhang, Alexander B Sibley, Joe R Delaney, Amy J Wisdom, Xiaodi Qin, Xi Wang, Isibel Caraballo, Jeremy Gresham, Lixia Luo, David Van Mater, Kouros Owzar, David G Kirsch
JournalJCI insight (JCI Insight) Vol. 4 Issue 13 (07 11 2019) ISSN: 2379-3708 [Electronic] United States
PMID31112524 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Carcinogens
  • Trp53 protein, mouse
  • Tumor Suppressor Protein p53
  • Methylcholanthrene
  • Hras protein, mouse
  • Proto-Oncogene Proteins p21(ras)
Topics
  • Animals
  • Carcinogenesis (genetics, radiation effects)
  • Carcinogens (toxicity)
  • DNA Mutational Analysis
  • Genomic Instability (radiation effects)
  • Humans
  • Methylcholanthrene (toxicity)
  • Mice
  • Neoplasms, Experimental (chemically induced, genetics)
  • Neoplasms, Radiation-Induced (genetics)
  • Oncogenes (genetics, radiation effects)
  • Proto-Oncogene Proteins p21(ras) (genetics)
  • Sarcoma (chemically induced, genetics)
  • Tumor Suppressor Protein p53 (genetics)
  • Exome Sequencing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: